ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

In Brief: NIH Intramural Research Said Needing Better Peer Review, Change In Selecting Counselors

April 23, 1976

Murphy Withdraws From SU Position

October 17, 1986

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985